D A Chamberlain - Concepedia

Concepedia

Author

D A Chamberlain

Royal Sussex County Hospital

Also Known As

D A Chamberlain, D Chamberlain, D. A. Chamberlain, D. CHAMBERLAIN, D. Chamberlain, D.A. Chamberlain, DA Chamberlain, Douglas Chamberlain

32

Publications

2.4K

Citations

14

H-Index

60

Concepts

All Affiliations

Royal Sussex County Hospital

DA

About

D A Chamberlain is an author at Royal Sussex County Hospital specializing in medicine, cardiology, and emergency medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	1.7K
2	Engineering	3	3	106
3	Health Sciences	1	1	14
4	Public Health	1	1	903
5	Allergy	1	1	12

D A Chamberlain

×

14

Publications

2.4K

Citations

13

H-Index

	Year	Citations
Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial P A Poole-Wilson, RA Henderson, D A Chamberlain, The Lancet ThrombosisPercutaneous Coronary InterventionHealth PolicyCardiovascular DiseaseUnstable Angina	2002	903
Combination antithrombotic therapy in unstable rest angina and non-Q-wave infarction in nonprior aspirin users. Primary end points analysis from the ATACS trial. Antithrombotic Therapy in Acute Coronary Syndromes Research Group. Marc Cohen, Philip C. Adams, G. Parry, Circulation	1994	380
Coronary angioplasty versus coronary artery bypass surgery: the Randomized Intervention Treatment of Angina (RITA) trial. Hampton, RA Henderson, D G Julian, PubMed	1993	274
Use of an automated external de fibrillation pacemaker by ambulance staff N S V Jaggarao, Mary E. Heber, R.M. Grainger, The Lancet Electrophysiological EvaluationCardiopulmonary ResuscitationFibrillation PacemakerDevice TherapyPatient Safety	1982	200
pEmu: an improved promoter for gene expression in cereal cells D. I. Last, R. I. S. Brettell, D A Chamberlain, Theoretical and Applied Genetics Transcriptional RegulationGeneticsGenetic EngineeringGene RegulationGene Expression	1991	195
ORAL MEXILETINE IN HIGH-RISK PATIENTS AFTER MYOCARDIAL INFARCTION D A Chamberlain, Desmond G. Julian, D.Mcc. Boyle, The Lancet ThrombosisCardiovascular DiseasePharmacotherapyPlatelet AntagonistMedicine	1980	176
Ocular changes resulting from therapy with amiodarone. D V Ingram, N S V Jaggarao, D A Chamberlain British Journal of Ophthalmology Stable PatternOcular DiseaseOphthalmologyExperimental OphthalmologySerial Observations	1982	69
The Use of the Emu Promoter With Antibiotic and Herbicide Resistance Genes for the Selection of Transgenic Wheat Callus and Rice Plants D A Chamberlain, RIS Brettell, DI Last, Australian Journal of Plant Physiology Plant GeneticsEngineeringGeneticsTransgenic Wheat CallusMolecular Genetics	1994	54
Recommended guidelines for uniform reporting of data from out-of-hospital cardiac arrest: the Utstein Style. Task Force of the American Heart Association, the European Resuscitation Council, the Heart and Stroke Foundation of Canada, and the Australian Resuscitation Council. R O Cummins, D A Chamberlain, N S Abramson, PubMed Trauma ResuscitationCardiopulmonary ResuscitationMedicinePatient SafetyTask Force	1991	41
Plant Regeneration from Protoplasts of <i>Trifolium repens</i> and <i>Lotus corniculatus</i> K. Judith Webb, Sarah C. Woodcock, D A Chamberlain Plant Breeding BiologyDevelopmental BiologyEngineeringBotanyGenetics	1987	38

Page 1